NCT05869279View on ClinicalTrials.gov

Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2027

Conditions
B-cell NHLCLL
Interventions
BIOLOGICAL

CARCIK-CD19

allogeneic cytokine induced killer cells transduced with a transposon CD19-chimeric antigen receptor (CARCIK-CD19) gene

Trial Locations (1)

24127

RECRUITING

Ospedale Papa Giovanni XXIII, Bergamo

All Listed Sponsors
lead

Fondazione Matilde Tettamanti Menotti De Marchi Onlus

OTHER